deferoxamine has been researched along with Necrotizing Pyelonephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganguly, NK; Gupta, R; Gupta, S; Joshi, K | 1 |
| Dittrich, P; Huber, H; Stühlinger, W | 1 |
2 other study(ies) available for deferoxamine and Necrotizing Pyelonephritis
| Article | Year |
|---|---|
Role of iron and iron chelation therapy in oxygen free radical mediated tissue injury in an ascending mouse model of chronic pyelonephritis.
Topics: Animals; Chelation Therapy; Chronic Disease; Citric Acid; Deferoxamine; Disease Models, Animal; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Ferric Compounds; Free Radicals; Glucosephosphate Dehydrogenase; Glutathione Reductase; Histocytochemistry; Iron; Kidney; L-Lactate Dehydrogenase; Lipid Peroxides; Luminescent Measurements; Mice; Mice, Inbred BALB C; Pyelonephritis; Reactive Oxygen Species; Sorbitol | 1997 |
[Studies on clearance of Fe59-tagged desferrioxamine in healthy kidney function and kidney diseases].
Topics: Aminohippuric Acids; Deferoxamine; Glomerulonephritis; Humans; Iron Isotopes; Kidney; Kidney Function Tests; Nephrosclerosis; Pyelonephritis | 1966 |